These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2466942)
1. Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes. Kuwano K; Scott M; Young JF; Ennis FA J Exp Med; 1989 Apr; 169(4):1361-71. PubMed ID: 2466942 [TBL] [Abstract][Full Text] [Related]
2. HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response. Kuwano K; Scott M; Young JF; Ennis FA J Immunol; 1988 Feb; 140(4):1264-8. PubMed ID: 2449498 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins. Kuwano K; Braciale TJ; Ennis FA Viral Immunol; 1989; 2(3):163-73. PubMed ID: 2483503 [TBL] [Abstract][Full Text] [Related]
4. Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli. Yamada A; Ziese MR; Young JF; Yamada YK; Ennis FA J Exp Med; 1985 Aug; 162(2):663-74. PubMed ID: 3160807 [TBL] [Abstract][Full Text] [Related]
5. Recognition of disparate HA and NS1 peptides by an H-2Kd-restricted, influenza specific CTL clone. Kuwano K; Reyes VE; Humphreys RE; Ennis FA Mol Immunol; 1991; 28(1-2):1-7. PubMed ID: 1707132 [TBL] [Abstract][Full Text] [Related]
6. Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone. Kuwano K; Tamura M; Ennis FA Virology; 1990 Sep; 178(1):174-9. PubMed ID: 1697125 [TBL] [Abstract][Full Text] [Related]
7. Immunization with the N-terminal region of the nonstructural protein NS1 promotes survival after challenge with lethal influenza A virus dose. Tamura M; Saikh KU; Kurane I; Ennis FA Viral Immunol; 1998; 11(3):131-5. PubMed ID: 9918404 [TBL] [Abstract][Full Text] [Related]
8. Protective cross-reactive epitope on the nonstructural protein NS1 of influenza A virus. Saikh KU; Tamura M; Kuwano K; Dai LC; West K; Ennis FA Viral Immunol; 1993; 6(4):229-36. PubMed ID: 7513168 [TBL] [Abstract][Full Text] [Related]
9. Influenza A virus-specific H-2d restricted cross-reactive cytotoxic T lymphocyte epitope(s) detected in the hemagglutinin HA2 subunit of A/Udorn/72. Saikh KU; Martin JD; Nishikawa AH; Dillon SB Virology; 1995 Dec; 214(2):445-52. PubMed ID: 8553546 [TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge. Fries LF; Dillon SB; Hildreth JE; Karron RA; Funkhouser AW; Friedman CJ; Jones CS; Culleton VG; Clements ML J Infect Dis; 1993 Mar; 167(3):593-601. PubMed ID: 8440931 [TBL] [Abstract][Full Text] [Related]
11. Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin. Wabuke-Bunoti MA; Taku A; Fan DP; Kent S; Webster RG J Immunol; 1984 Oct; 133(4):2194-201. PubMed ID: 6206156 [TBL] [Abstract][Full Text] [Related]
12. Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein. Mbawuike IN; Dillion SB; Demuth SG; Jones CS; Cate TR; Couch RB Vaccine; 1994 Nov; 12(14):1340-8. PubMed ID: 7856302 [TBL] [Abstract][Full Text] [Related]
13. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design. Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of influenza haemagglutinin and nucleoprotein as protective antigens against influenza virus infection in mice. Andrew ME; Coupar BE Scand J Immunol; 1988 Jul; 28(1):81-5. PubMed ID: 2456608 [TBL] [Abstract][Full Text] [Related]
15. Influenza virus subtype-specific cytotoxic T lymphocytes lyse target cells coated with a protein produced in E. coli. Yamada A; Young JF; Ennis FA J Exp Med; 1985 Nov; 162(5):1720-5. PubMed ID: 3903026 [TBL] [Abstract][Full Text] [Related]
16. Induction and activity of class II-restricted, Lyt-2+ cytolytic T lymphocytes specific for the influenza H5 hemagglutinin. Hioe CE; Hinshaw VS J Immunol; 1989 Apr; 142(7):2482-8. PubMed ID: 2466897 [TBL] [Abstract][Full Text] [Related]
17. The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen. Milligan GN; Morrison LA; Gorka J; Braciale VL; Braciale TJ J Immunol; 1990 Nov; 145(10):3188-93. PubMed ID: 1700000 [TBL] [Abstract][Full Text] [Related]
18. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites. Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794 [TBL] [Abstract][Full Text] [Related]
19. Mouse H-2k-restricted cytotoxic T cells recognize antigenic determinants in both the HA1 and HA2 subunits of the influenza A/PR/8/34 hemagglutinin. Gould KG; Scotney H; Townsend AR; Bastin J; Brownlee GG J Exp Med; 1987 Sep; 166(3):693-701. PubMed ID: 2442286 [TBL] [Abstract][Full Text] [Related]
20. Induction of cytotoxic T lymphocytes of heterogeneous specificities by immunization with a single peptide derived from influenza A virus. Masaki H; Tamura M; Kurane I Viral Immunol; 2000; 13(1):73-81. PubMed ID: 10733170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]